Removal of water-soluble and protein-bound solutes with reversed mid-dilution versus post-dilution haemodiafiltration
- PMID: 22492823
- DOI: 10.1093/ndt/gfs060
Removal of water-soluble and protein-bound solutes with reversed mid-dilution versus post-dilution haemodiafiltration
Abstract
Background: Convective dialysis strategies are superior in the removal of protein-bound uraemic retention solutes. Mid-dilution and mixed-dilution haemodiafiltration (HDF), both combining pre-dilution and post-dilution, are promising options to further improve removal capacity and have been shown of additional benefit for large middle molecules. In this study, we compared the removal of small water-soluble and protein-bound solutes in post-dilution versus mid-dilution HDF.
Methods: Fourteen chronic haemodialysis (HD) patients were included in this crossover study. Patients were kept for 4 weeks on high-flux HD. On the mid-week session of Weeks 3 and 4, either post-dilution or reversed mid-dilution HDF were applied, in random order. Blood and dialysate flows were maintained at 300 and 800 mL/min, while the substitution flow was 75 mL/min in post-dilution and 150 mL/min in mid-dilution HDF. Based on the data collected during the sessions under study, extraction ratio (ER) and reduction ratio (RR) of small water-soluble and protein-bound solutes were calculated, as well as total solute removal (TSR) based on spent dialysate.
Results: No differences were observed for TSR, ER and RR for protein-bound solutes. For small water-soluble solutes, ER in post-dilution HDF was significantly higher than in mid-dilution HDF: 0.92 ± 0.02 versus 0.87 ± 0.04 for urea (P < 0.001), 0.92 ± 0.02 versus 0.88 ± 0.02 for creatinine (P < 0.001) and 0.84 ± 0.02 versus 0.82 ± 0.03 for uric acid (P = 0.009). TSR and RR were, however, not different due to the lower inlet concentrations with post-dilution HDF.
Conclusions: TSR of mid-dilution and post-dilution HDF was not different for both small water-soluble and protein-bound compounds. Both strategies in the setting as applied in this study are as adequate for the removal of these solutes.
Similar articles
-
Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial.Nephrol Dial Transplant. 2009 Feb;24(2):562-70. doi: 10.1093/ndt/gfn522. Epub 2008 Sep 22. Nephrol Dial Transplant. 2009. PMID: 18809977 Clinical Trial.
-
Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.Nephrol Dial Transplant. 2010 Jan;25(1):212-8. doi: 10.1093/ndt/gfp437. Epub 2009 Sep 15. Nephrol Dial Transplant. 2010. PMID: 19755476 Clinical Trial.
-
Optimization of mid-dilution haemodiafiltration: technique and performance.Nephrol Dial Transplant. 2009 Sep;24(9):2816-24. doi: 10.1093/ndt/gfp207. Epub 2009 May 6. Nephrol Dial Transplant. 2009. PMID: 19420103 Clinical Trial.
-
Online hemodiafiltration.Artif Organs. 2006 Aug;30(8):579-85. doi: 10.1111/j.1525-1594.2006.00266.x. Artif Organs. 2006. PMID: 16911311 Review.
-
On-line hemodiafiltration as routine treatment of end-stage renal failure: why pre- or mixed dilution mode is necessary in on-line hemodiafiltration today?Blood Purif. 2004;22 Suppl 2:40-8. doi: 10.1159/000081874. Blood Purif. 2004. PMID: 15655323 Review.
Cited by
-
Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients.Int J Mol Sci. 2020 Feb 23;21(4):1522. doi: 10.3390/ijms21041522. Int J Mol Sci. 2020. PMID: 32102247 Free PMC article.
-
Dialyzer Reuse and Outcomes of High Flux Dialysis.PLoS One. 2015 Jun 9;10(6):e0129575. doi: 10.1371/journal.pone.0129575. eCollection 2015. PLoS One. 2015. PMID: 26057383 Free PMC article.
-
Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico.PLoS One. 2016 Apr 7;11(4):e0153157. doi: 10.1371/journal.pone.0153157. eCollection 2016. PLoS One. 2016. PMID: 27055286 Free PMC article.
-
Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?PLoS One. 2016 May 26;11(5):e0156541. doi: 10.1371/journal.pone.0156541. eCollection 2016. PLoS One. 2016. PMID: 27228162 Free PMC article. Clinical Trial.
-
The Choice of Anti-Inflammatory Influences the Elimination of Protein-Bound Uremic Toxins.Toxins (Basel). 2024 Dec 16;16(12):545. doi: 10.3390/toxins16120545. Toxins (Basel). 2024. PMID: 39728803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources